PNA-CONJUGATES FOR TREATING CHRONIC MYELOID LEUKEMIA (CML)

摘要

The invention concerns peptide-nucleic acid- (PNA) conjugates inhibiting the expression of the fusion bcr/abl gene characteristic of chronic myeloid leukaemia (CML), and suited to the treatment of CML.